BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...respiratory syncytial virus (RSV). CR-CP Life Sciences Fund led the round, with participation from Andera Partners, Brace Pharma Capital...
BioCentury | Aug 13, 2020
Finance

F2G raises $60.8M to get new class of antifungal to market

...CEO, and Tony Kennedy is chief scientific and development officer.Existing investors Novo Holdings, Morningside Ventures, Brace Pharma Capital...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...from undisclosed investors and appointed Eric Richman as CEO. He was a venture partner at Brace Pharma Capital...
BioCentury | Dec 19, 2019
Financial News

Versant’s Pipeline raises $30M series B for regenerative therapies

...myelin around the axon to address the root cause of MS. Sectoral’s Stefan Larson and Brace Pharma Capital’s...
BioCentury | Nov 13, 2019
Finance

Conjugate company Avidity preps for first dystrophy study with $100M series C

...as well as returning investors Alethea Capital, Alexandria Venture Investments, Boxer Capital of Tavistock Group, Brace Pharma Capital...
BioCentury | Aug 3, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma Capital...
BioCentury | Aug 1, 2018
Finance

Safety goes (Re)Viral

...and saw participation from new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma Capital...
BioCentury | Aug 1, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma Capital...
BioCentury | Jun 29, 2018
Financial News

Precision BioSciences raises $110M in series B

...led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital...
...round. Precision BioSciences Inc., Durham, N.C. Jaime De Leon Adage Capital Management Agent Capital Alexandria Venture Investments Amgen Ventures Arrowmark Partners Baxalta Inc. Brace Pharma Capital Cormorant...
BioCentury | Jun 26, 2018
Financial News

Precision BioSciences raises $110M in series B

...led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital...
...in its 2015 series A round. Jaime De Leon Adage Capital Management Agent Capital Alexandria Venture Investments Amgen Ventures Arrowmark Partners Baxalta Inc. Brace Pharma Capital Cormorant...
Items per page:
1 - 10 of 31
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...respiratory syncytial virus (RSV). CR-CP Life Sciences Fund led the round, with participation from Andera Partners, Brace Pharma Capital...
BioCentury | Aug 13, 2020
Finance

F2G raises $60.8M to get new class of antifungal to market

...CEO, and Tony Kennedy is chief scientific and development officer.Existing investors Novo Holdings, Morningside Ventures, Brace Pharma Capital...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...from undisclosed investors and appointed Eric Richman as CEO. He was a venture partner at Brace Pharma Capital...
BioCentury | Dec 19, 2019
Financial News

Versant’s Pipeline raises $30M series B for regenerative therapies

...myelin around the axon to address the root cause of MS. Sectoral’s Stefan Larson and Brace Pharma Capital’s...
BioCentury | Nov 13, 2019
Finance

Conjugate company Avidity preps for first dystrophy study with $100M series C

...as well as returning investors Alethea Capital, Alexandria Venture Investments, Boxer Capital of Tavistock Group, Brace Pharma Capital...
BioCentury | Aug 3, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma Capital...
BioCentury | Aug 1, 2018
Finance

Safety goes (Re)Viral

...and saw participation from new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma Capital...
BioCentury | Aug 1, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma Capital...
BioCentury | Jun 29, 2018
Financial News

Precision BioSciences raises $110M in series B

...led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital...
...round. Precision BioSciences Inc., Durham, N.C. Jaime De Leon Adage Capital Management Agent Capital Alexandria Venture Investments Amgen Ventures Arrowmark Partners Baxalta Inc. Brace Pharma Capital Cormorant...
BioCentury | Jun 26, 2018
Financial News

Precision BioSciences raises $110M in series B

...led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital...
...in its 2015 series A round. Jaime De Leon Adage Capital Management Agent Capital Alexandria Venture Investments Amgen Ventures Arrowmark Partners Baxalta Inc. Brace Pharma Capital Cormorant...
Items per page:
1 - 10 of 31